NMC Section 6 for Doctors: 2026 Social Media Rules & Penalties

Section 6 of the NMC Code of Professional Ethics is the provision that most healthcare marketing agencies get wrong — and that most doctors find confusing in its application to social media.

This guide is ICG's working reference. We apply this framework to every piece of content produced for 150+ healthcare clients. Zero formal NMC, DCI, or CDSCO complaints since 2018 across that portfolio.

What the 2026 revision changed

The NMC Code received its most substantive update in several years in 2026. For social media specifically, five changes matter:

Change 1: Digital content explicitly included in Section 6's scope. Prior versions of the Code referenced "advertising" without expressly defining whether social media posts, YouTube videos, website copy, or WhatsApp Broadcast messages fell within the definition. The 2026 revision explicitly includes all digital content produced by or on behalf of a registered medical practitioner.

Change 2: Educational content carve-out formalised. The distinction between promotional content (regulated by Section 6) and educational content (explicitly excluded) was implicit in the prior Code. The 2026 revision makes it explicit: content that serves patient health literacy, scientific education, or public health awareness — without primarily promoting a specific practice or soliciting patients — is outside Section 6's advertising restrictions.

Change 3: Influencer-marketing provision introduced. Any content produced by a registered medical practitioner for a third-party platform — a supplement brand's Instagram, a health startup's YouTube, a cosmetic company's website — for commercial consideration is now deemed advertising under Section 6 and must comply with its prohibitions. This targets the practice of doctors producing paid content for non-clinical brands.

Change 4: Named-patient reference standards clarified. The identifiability standard for the before-and-after prohibition is now explicit: a patient is identifiable if they can be identified by their face, by unique physical characteristics, or by contextual details that make identification likely even without their name.

Change 5: Patient testimonial consent framework strengthened. Every patient testimonial used in any doctor's or clinic's advertising must be accompanied by documented informed consent specifying: the purpose for which the testimonial will be used, the platforms on which it will appear, the duration of use, and the right of withdrawal. This intersects with DPDP Act 2023 consent requirements.

The 12-point pre-publication checklist

AI Overview opportunity across YouTube search, Google web and Google AI Overview" width="1200" height="675" loading="lazy" decoding="async" style="width:100%;height:auto;display:block;">

ICG runs every piece of healthcare content through this checklist before publishing. Apply it to every social media post, Reel, Story, YouTube video, blog article, and WhatsApp Broadcast.

1. Primary intent check: Does this content primarily educate or primarily solicit?

• If primarily educating: educational carve-out — proceed with checks 2-12
• If primarily soliciting: is the solicitation factual and non-manipulative? (Factual promotion of services is permitted; manipulative solicitation is not)

2. Outcome guarantee scan: Does the content contain any of these phrases or their equivalents? "Guaranteed results" / "100% success" / "cure" / "eliminate permanently" / "you will achieve X" / "no side effects" / "risk-free"

• If yes: remove or replace with population-level statistics from published research with individual-variability qualifiers

3. Before-and-after imagery check: Does the content show or reference patient before-and-after imagery?

• If yes: is the patient identifiable? (Face visible / unique physical characteristics / contextual identification)
• If identifiable: remove or anonymise to meet the 2026 identifiability standard

4. Schedule J compliance check: Does the content reference a specific drug treatment for a Schedule J condition in patient-facing language? Schedule J conditions include: cancer, diabetes, heart disease, blood pressure, mental illness, alopecia (hair loss), sterility, STDs, and 46 others.

• If yes: reframe as service description ("our diabetes management programme") not drug claim ("our [drug] treatment for diabetes")

5. Superlative claim check: Does the content use "best", "leading", "top", "India's #1", "most experienced", or equivalent?

• If yes: is the claim specifically and verifiably substantiated?
• If not substantiated: remove or replace with a specific factual claim ("2,000+ IVF cycles performed", "15 years of subspecialty experience")

6. Patient data check: Does the content use any patient's name, face, age, location, or clinical details?

• If yes: is DPDP Act 2023 informed consent documented?
• Consent must specify: purpose, platforms, duration, withdrawal right
• If not documented: remove the patient-identifying element

7. Specialisation boundary check: Is the content authored by or attributed to a registered medical practitioner?

• If yes: does the content reflect only their registered specialisation?
• An MDS Orthodontist advertising "full dental services including implants and oral surgery" advertises outside specialisation

8. Safety messaging check: Does the content imply that a patient should avoid, delay, or substitute conventional medical care?

• If yes: remove. NMC does not permit content that discourages appropriate medical care.

9. Paid endorsement check: Does the content involve any paid endorsement or product placement?

• If yes: is the paid partnership disclosed? (Mandatory under ASCI guidelines and the 2026 NMC influencer provision)

10. ART Act check (IVF/fertility content only): Does the content make success rate claims for ART procedures? Does the content promote commercial surrogacy? Does the content imply guaranteed outcomes for ART?

• If any yes: remove. ART Act 2021 prohibits all three.

11. DCI check (dental content only): Does the content disclose the practitioner's MDS specialisation? Does the content create undue anxiety about oral health to solicit patients?

• If the first is missing: add specialisation disclosure
• If the second is present: remove the anxiety-creating element

12. Compliance footnote: Does the content carry (or link to) the ICG compliance footnote? "This content has been reviewed against NMC Section 6 advertising provisions, Schedule J restrictions, and DPDP Act 2023 protocols."

• Add to every blog article and YouTube description. Not required on individual social media posts but on the profile/about page.

What is specifically permitted vs prohibited

Permitted under Section 6:

Prohibited under Section 6:

The enforcement landscape in 2026

NMC Section 6 enforcement is complaint-driven. The most common complaint triggers (ICG analysis of available enforcement summaries):

1. Before-and-after imagery of identifiable patients — the most-filed complaint type in cosmetic specialties. Competitor clinics are increasingly filing these complaints in competitive markets.
2. Outcome guarantee language in paid Google or Meta Ads — patients who act on an ad and feel misled by the outcome gap are the most likely complainants.
3. Unsubstantiated superlative claims on websites — "best dermatologist in Bandra" without evidence is the specific phrase type that triggers competitor and patient complaints.

The penalty range:

• Formal warning (most common for first-time, non-patient-harm violations)
• Public censure entered on the register
• Suspension of medical registration (for serious, repeated, or patient-harm-causing violations)

Competitor-filed complaints: This mechanism has increased in urban markets — competing clinics filing NMC Section 6 complaints against competitors whose marketing is non-compliant. It is being used strategically to remove competitive advertising in high-margin specialties (IVF, hair transplant, aesthetic derm). A compliance programme is not just about ethics — it is competitive protection.

Read next on ICG

Meta Catalyst IQ Master Dashboard showing account-level KPIs, spend, CPQL and campaign health for a healthcare Meta Ads account" width="1200" height="675" loading="lazy" decoding="async" style="width:100%;height:auto;display:block;">

• Why ICG — methodology
• About ICG — healthcare-only compliance
• Digital marketing agency for doctors (India)

Nine common Section 6 mistakes that trigger warnings in 2026

Across roughly 40 clinic and hospital audits our team has run in the last twelve months, the same handful of Section 6 breaches keep showing up. None of them look risky on the surface. Most are pushed live by an outsourced reel editor or a junior admin who has never read the Code of Ethics Regulations. The State Medical Council does not care who pressed publish — the registered practitioner named on the account carries the liability.

Here is the pattern we see most often, ranked by how frequently it appears in complaint files:

1. Before-and-after images without written consent on file. A WhatsApp voice note does not qualify. The council asks for a signed form with the patient's name, MRN, procedure, date, and explicit social-media clause.
2. Testimonial reels where the patient names the doctor as 'the best'. Superlative language shifts the reel from information to solicitation, which is exactly what Section 6 prohibits.
3. Live-surgery streams without a disclaimer and without pre-approved commentary. Common in cosmetic and dental practice; the reel usually gets flagged when a competitor's PR agency archives it.
4. Success-rate claims quoted as percentages ("98% success in IVF", "zero-complication cataract") without a linked peer-reviewed source.
5. Paid promotion of clinic services on the personal handle of the registered doctor.
6. Cross-tagging a pharma brand or device manufacturer in a case-study post — this is treated as endorsement.
7. Comment sections left un-moderated where staff reply with pricing, availability, or DM prompts.
8. Reposting a patient's own review reel without re-securing consent for the doctor's handle audience.
9. Reels stitched with a viral trending audio that jokes about a medical condition — repeatedly flagged in 2026 for 'undignified conduct'.

Most of these are one-line fixes once the workflow exists. If you're building that workflow from scratch, our Client Elevation Programme ships a Section 6 pre-publication SOP as part of the compliance kit — the same one used by the NABH hospitals we run content for. Practices that publish Instagram Reels at scale usually pair it with Prism Pulse so the compliance reviewer can see, in one dashboard, which reels are live, which are archived, and which are still awaiting sign-off. For YouTube-first practices, YODA holds the same audit trail for long-form videos and Shorts.

The reason to close these gaps now, and not after a notice arrives, is bureaucratic: a Section 6 complaint takes six to eighteen months to reach a hearing, but the clinic's social handles are usually asked to freeze new posts in the interim. A single competitor complaint can pull an active handle off the market for a full growth quarter.

What should a practice do the hour a Section 6 complaint or SMC notice arrives?

Prism Pulse Overview dashboard for a healthcare Instagram account showing 30-day views, reach, interactions and net follows with an AI-summarised what-is-working panel" width="1200" height="675" loading="lazy" decoding="async" style="width:100%;height:auto;display:block;">

Freeze the handle, preserve every post in a dated folder, and stop all scheduled content across the practice's channels before drafting a reply to the State Medical Council. The 30-day reply window in a Section 6 notice sounds generous, but the evidence you'll need to defend the account has to be captured in the first 24 to 72 hours, before caches expire and Instagram Stories drop off.

The first 72 hours: freeze, preserve, catalogue

Pause every scheduled post across Instagram, LinkedIn, YouTube Shorts and any regional handle the practice runs. One Bengaluru dermatology practice had dozens of Reels queued across three sub-handles when the notice arrived, and the queue kept firing while the review clock ran. Screenshot the flagged post, the caption, the comments, and any reshares. Export the post's Insights CSV. Save the WhatsApp brief that led to the post being made. Store all of it in one dated folder on the clinic's drive, not on the handle owner's phone.

DPDP-linked artefacts the SMC can ask for

Under the DPDP Act 2023, a clinic is a Data Fiduciary the moment a patient's face, ABHA number, or identifiable case history appears in a caption. If the complaint is about a testimonial or a before/after visual, you'll need the signed consent form (with the specific "publication on Instagram / YouTube" tick), the date of consent, the person who took the consent, and proof that consent wasn't bundled with the treatment agreement. Bundled consent is void under the DPDP Act's specific-purpose rule. The SMC will read that as a Section 6 breach on the NMC side too.

Running the agency handoff without a second breach

Most Section 6 notices we've seen at ICG traced back to a marketing agency posting on behalf of the doctor without a countersigned brief. During the review, brief the agency in writing on what content to hold, which archived posts to soft-hide (never delete, that itself becomes evidence), and who owns the reply to the SMC. Our 70-30 retainer model bakes this in: 70% of the fee covers content and paid-media execution, 30% covers governance, including a per-post compliance log the SMC can be shown on request. During a live notice, CPQL usually jumps from the healthcare benchmark of about Rs 450 to over Rs 1,200 for two to four weeks while the handle is frozen; budget for it.

FAQs on responding to a Section 6 notice

Can we delete the flagged post before we reply? No. Deletion after receipt of a notice is treated as evidence tampering by most State Medical Councils. Archive or soft-hide the post so it isn't publicly visible, keep the original file, and mention the archival in your written reply.

Does an ABHA number in the caption count as a DPDP breach even if the patient consented verbally? Yes. ABHA is a national health identifier under ABDM; publishing it needs written, specific, un-bundled consent under the DPDP Act 2023. Verbal consent is not defensible in a Section 6 or DPDP hearing.